Hiroshi Miyamoto

GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer

Y. Teramoto, Mohammad Amin Elahi Najafi, Masato Yasui, 2023, International journal of molecular sciences.

The Role of Adipocytokines and their Receptors in Prostate Cancer: Adiponectin May Protect Against Progression

M. Shiota, J. Inokuchi, F. Kinoshita, 2024, AntiCancer Research.

Latrophilin-3 as a downstream effector of the androgen receptor induces bladder cancer progression

T. Goto, Y. Nagata, Hiroshi Miyamoto, 2024, Discover oncology.

Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer.

A. Ikari, N. Fujimoto, Y. Nagata, 2023, Chemico-biological interactions.

Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression

E. Kashiwagi, H. Ide, Yichun Zheng, 2019, Molecular carcinogenesis.

Mineralocorticoid receptor signaling inhibits bladder cancer progression.

T. Goto, Y. Nagata, Takuo Matsukawa, 2024, American journal of cancer research.

Association of Androgen Receptor and PD-L1 Expression in Upper Urinary Tract Urothelial Carcinoma

Yohei Okuda, Hiroshi Miyamoto, Taigo Kato, 2024, Cancer Genomics & Proteomics.